Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid.

Terao M, Goracci L, Celestini V, Kurosaki M, Bolis M, Di Veroli A, Vallerga A, Fratelli M, Lupi M, Corbelli A, Fiordaliso F, Gianni M, Paroni G, Zanetti A, Cruciani G, Garattini E.

J Exp Clin Cancer Res. 2019 Dec 18;38(1):496. doi: 10.1186/s13046-019-1485-4.

2.

Use of Phenotypically Poor Metabolizer Individual Donor Human Liver Microsomes To Identify Selective Substrates of UGT2B10.

Milani N, Qiu N, Molitor B, Badée J, Cruciani G, Fowler S.

Drug Metab Dispos. 2020 Mar;48(3):176-186. doi: 10.1124/dmd.119.089482. Epub 2019 Dec 15.

PMID:
31839590
3.

A Novel Lipidomics-Based Approach to Evaluating the Risk of Clinical Hepatotoxicity Potential of Drugs in 3D Human Microtissues.

Goracci L, Valeri A, Sciabola S, Aleo MD, Moritz W, Lichtenberg J, Cruciani G.

Chem Res Toxicol. 2020 Jan 21;33(1):258-270. doi: 10.1021/acs.chemrestox.9b00364. Epub 2019 Dec 24.

PMID:
31820940
4.

Bisphenol A binding promiscuity: A virtual journey through the universe of proteins.

Lo Piparo E, Siragusa L, Raymond F, Passeri GI, Cruciani G, Schilter B.

ALTEX. 2020;37(1):85-94. doi: 10.14573/altex.1906141. Epub 2019 Nov 8.

5.

A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.

Celegato M, Messa L, Goracci L, Mercorelli B, Bertagnin C, Spyrakis F, Suarez I, Cousido-Siah A, Travé G, Banks L, Cruciani G, Palù G, Loregian A.

Cancer Lett. 2020 Feb 1;470:115-125. doi: 10.1016/j.canlet.2019.10.046. Epub 2019 Nov 3.

PMID:
31693922
6.

Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid.

Terao M, Goracci L, Celestini V, Kurosaki M, Bolis M, Di Veroli A, Vallerga A, Fratelli M, Lupi M, Corbelli A, Fiordaliso F, Gianni M, Paroni G, Zanetti A, Cruciani G, Garattini E.

J Exp Clin Cancer Res. 2019 Oct 29;38(1):436. doi: 10.1186/s13046-019-1438-y. Erratum in: J Exp Clin Cancer Res. 2019 Dec 18;38(1):496.

7.

Heart rate variability in response to the recall of attachment memories.

Zingaretti P, Giovanardi G, Cruciani G, Lingiardi V, Ottaviani C, Spitoni GF.

Attach Hum Dev. 2019 Oct 24:1-10. doi: 10.1080/14616734.2019.1680712. [Epub ahead of print]

PMID:
31646928
8.

Titanium Dioxide-Based Nanocomposites for Enhanced Gas-Phase Photodehydrogenation.

Zanardo D, Ghedini E, Menegazzo F, Cattaruzza E, Manzoli M, Cruciani G, Signoretto M.

Materials (Basel). 2019 Sep 23;12(19). pii: E3093. doi: 10.3390/ma12193093.

9.

How computational chemistry develops: a tribute to Peter Goodford.

Cruciani G, Martin Y, Vinter A, Lewis R, Gago F, Stouch TR.

J Comput Aided Mol Des. 2019 Aug;33(8):699-703. doi: 10.1007/s10822-019-00217-9.

PMID:
31435893
10.

Redox lipidomics and adductomics - Advanced analytical strategies to study oxidized lipids and lipid-protein adducts.

Cruciani G, Domingues P, Fedorova M, Galli F, Spickett CM.

Free Radic Biol Med. 2019 Nov 20;144:1-5. doi: 10.1016/j.freeradbiomed.2019.07.027. Epub 2019 Jul 29. No abstract available.

PMID:
31369839
11.

A computational study toward the "personalized" activity of alternariol - Does it matter for safe food at individual level?

Dellafiora L, Galaverna G, Cruciani G, Dall'Asta C.

Food Chem Toxicol. 2019 Aug;130:199-206. doi: 10.1016/j.fct.2019.05.033. Epub 2019 May 22.

PMID:
31128219
12.

Interaction of Mycotoxin Alternariol with Serum Albumin.

Fliszár-Nyúl E, Lemli B, Kunsági-Máté S, Dellafiora L, Dall'Asta C, Cruciani G, Pethő G, Poór M.

Int J Mol Sci. 2019 May 12;20(9). pii: E2352. doi: 10.3390/ijms20092352.

13.

Computational solutions in redox lipidomics - Current strategies and future perspectives.

Ni Z, Goracci L, Cruciani G, Fedorova M.

Free Radic Biol Med. 2019 Nov 20;144:110-123. doi: 10.1016/j.freeradbiomed.2019.04.027. Epub 2019 Apr 26. Review.

14.

Tactile sensitivity, tactile acuity, and affective touch: from childhood to early adolescence.

Zingaretti P, Petta AM, Cruciani G, Spitoni GF.

Somatosens Mot Res. 2019 Mar;36(1):90-96. doi: 10.1080/08990220.2019.1604334. Epub 2019 Apr 23.

PMID:
31012361
15.

Discovering New Casein Kinase 1d Inhibitors with an Innovative Molecular Dynamics Enabled Virtual Screening Workflow.

Sciabola S, Benedetti P, D'Arrigo G, Torella R, Baroni M, Cruciani G, Spyrakis F.

ACS Med Chem Lett. 2018 Dec 13;10(4):487-492. doi: 10.1021/acsmedchemlett.8b00523. eCollection 2019 Apr 11.

PMID:
30996784
16.

A Rapid Form of Offline Consolidation in Skill Learning.

Bönstrup M, Iturrate I, Thompson R, Cruciani G, Censor N, Cohen LG.

Curr Biol. 2019 Apr 22;29(8):1346-1351.e4. doi: 10.1016/j.cub.2019.02.049. Epub 2019 Mar 28.

PMID:
30930043
17.

Overview of the Biological Activities of a Methanol Extract from Wild Red Belt Conk, Fomitopsis pinicola (Agaricomycetes), Fruiting Bodies from Central Italy.

Angelini P, Tirillini B, Bistocchi G, Arcangeli A, Rubini A, Pellegrino RM, Fabiani R, Cruciani G, Venanzoni R, Rosignoli P.

Int J Med Mushrooms. 2018;20(11):1047-1063. doi: 10.1615/IntJMedMushrooms.2018028595.

PMID:
30806229
18.

Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH.

Torquato P, Giusepponi D, Alisi A, Galarini R, Bartolini D, Piroddi M, Goracci L, Di Veroli A, Cruciani G, Crudele A, Nobili V, Galli F.

Sci Rep. 2019 Feb 14;9(1):2045. doi: 10.1038/s41598-018-37209-y.

19.

Predicting Viscosity and Surface Tension at High Temperature of Porcelain Stoneware Bodies: A Methodological Approach.

Conte S, Zanelli C, Ardit M, Cruciani G, Dondi M.

Materials (Basel). 2018 Dec 6;11(12). pii: E2475. doi: 10.3390/ma11122475.

20.

Sensorimotor Oscillatory Phase-Power Interaction Gates Resting Human Corticospinal Output.

Hussain SJ, Claudino L, Bönstrup M, Norato G, Cruciani G, Thompson R, Zrenner C, Ziemann U, Buch E, Cohen LG.

Cereb Cortex. 2019 Aug 14;29(9):3766-3777. doi: 10.1093/cercor/bhy255.

PMID:
30496352
21.

On the Mechanism of Action of Anti-Inflammatory Activity of Hypericin: An In Silico Study Pointing to the Relevance of Janus Kinases Inhibition.

Dellafiora L, Galaverna G, Cruciani G, Dall'Asta C, Bruni R.

Molecules. 2018 Nov 22;23(12). pii: E3058. doi: 10.3390/molecules23123058.

22.

Physical Activity Modulates the Overexpression of the Inflammatory miR-146a-5p in Obese Patients.

Russo A, Bartolini D, Mensà E, Torquato P, Albertini MC, Olivieri F, Testa R, Rossi S, Piroddi M, Cruciani G, De Feo P, Galli F.

IUBMB Life. 2018 Oct;70(10):1012-1022. doi: 10.1002/iub.1926. Epub 2018 Sep 13.

23.

Delving into the Polar Lipidome by Optimized Chromatographic Separation, High-Resolution Mass Spectrometry, and Comprehensive Identification with Lipostar: Microalgae as Case Study.

La Barbera G, Antonelli M, Cavaliere C, Cruciani G, Goracci L, Montone CM, Piovesana S, Laganà A, Capriotti AL.

Anal Chem. 2018 Oct 16;90(20):12230-12238. doi: 10.1021/acs.analchem.8b03482. Epub 2018 Sep 24.

PMID:
30204416
24.

Synthetic Peptide Libraries. From random mixtures to in vivo testing.

Sandomenico A, Caporale A, Doti N, Cross S, Cruciani G, Chambery A, De Falco S, Ruvo M.

Curr Med Chem. 2018 Jul 15. doi: 10.2174/0929867325666180716110833. [Epub ahead of print]

PMID:
30009695
25.

Simultaneous removal of Pb(II), Cd(II) and bacteria from aqueous solution using amino-functionalized Fe3O4/NaP zeolite nanocomposite.

Zendehdel M, Ramezani M, Shoshtari-Yeganeh B, Cruciani G, Salmani A.

Environ Technol. 2019 Dec;40(28):3689-3704. doi: 10.1080/09593330.2018.1485750. Epub 2018 Jun 18.

PMID:
29873602
26.

Electrostatic recognition in substrate binding to serine proteases.

Waldner BJ, Kraml J, Kahler U, Spinn A, Schauperl M, Podewitz M, Fuchs JE, Cruciani G, Liedl KR.

J Mol Recognit. 2018 Oct;31(10):e2727. doi: 10.1002/jmr.2727. Epub 2018 May 22.

27.

Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases.

Santucci M, Spyrakis F, Cross S, Quotadamo A, Farina D, Tondi D, De Luca F, Docquier JD, Prieto AI, Ibacache C, Blázquez J, Venturelli A, Cruciani G, Costi MP.

Sci Rep. 2017 Dec 18;7(1):17716. doi: 10.1038/s41598-017-17399-7.

28.

From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions.

Cruciani G, Milani N, Benedetti P, Lepri S, Cesarini L, Baroni M, Spyrakis F, Tortorella S, Mosconi E, Goracci L.

J Med Chem. 2018 Jan 11;61(1):360-371. doi: 10.1021/acs.jmedchem.7b01552. Epub 2017 Dec 29.

PMID:
29240409
29.

Race and Ethnicity Do Not Clinically Associate with Quality of Life Among Patients with Chronic Severe Pain in a Federally Qualified Health Center.

Dhingra L, Schiller R, Teets R, Nosal S, Rodriguez S, Cruciani G, Barrett M, Ginzburg R, Ahmed E, Wasser T, Chen J, Shuman S, Crump C, Portenoy R.

Pain Med. 2018 Jul 1;19(7):1408-1418. doi: 10.1093/pm/pnx040.

PMID:
29117340
30.

ADME-Space: a new tool for medicinal chemists to explore ADME properties.

Bocci G, Carosati E, Vayer P, Arrault A, Lozano S, Cruciani G.

Sci Rep. 2017 Jul 25;7(1):6359. doi: 10.1038/s41598-017-06692-0.

31.

Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists.

Marinozzi M, Castro Navas FF, Maggioni D, Carosati E, Bocci G, Carloncelli M, Giorgi G, Cruciani G, Fontana R, Russo V.

J Med Chem. 2017 Aug 10;60(15):6548-6562. doi: 10.1021/acs.jmedchem.7b00091. Epub 2017 Jul 25.

PMID:
28741954
32.

Detecting similar binding pockets to enable systems polypharmacology.

Duran-Frigola M, Siragusa L, Ruppin E, Barril X, Cruciani G, Aloy P.

PLoS Comput Biol. 2017 Jun 29;13(6):e1005522. doi: 10.1371/journal.pcbi.1005522. eCollection 2017 Jun.

33.

Crystalline Microporous Organosilicates with Reversed Functionalities of Organic and Inorganic Components for Room-Temperature Gas Sensing.

Fabbri B, Bonoldi L, Guidi V, Cruciani G, Casotti D, Malagù C, Bellussi G, Millini R, Montanari L, Carati A, Rizzo C, Montanari E, Zanardi S.

ACS Appl Mater Interfaces. 2017 Jul 26;9(29):24812-24820. doi: 10.1021/acsami.7b02122. Epub 2017 Jul 14.

PMID:
28657706
34.

Determination of tocopherols and their metabolites by liquid-chromatography coupled with tandem mass spectrometry in human plasma and serum.

Giusepponi D, Torquato P, Bartolini D, Piroddi M, Birringer M, Lorkowski S, Libetta C, Cruciani G, Moretti S, Saluti G, Galli F, Galarini R.

Talanta. 2017 Aug 1;170:552-561. doi: 10.1016/j.talanta.2017.04.030. Epub 2017 Apr 12.

PMID:
28501210
35.

Lipostar, a Comprehensive Platform-Neutral Cheminformatics Tool for Lipidomics.

Goracci L, Tortorella S, Tiberi P, Pellegrino RM, Di Veroli A, Valeri A, Cruciani G.

Anal Chem. 2017 Jun 6;89(11):6257-6264. doi: 10.1021/acs.analchem.7b01259. Epub 2017 May 12.

PMID:
28471643
36.

Use of the Distribution Coefficient in Brain Polar Lipids for the Assessment of Drug-Induced Phospholipidosis Risk.

Ceccarelli M, Wagner B, Alvarez-Sánchez R, Cruciani G, Goracci L.

Chem Res Toxicol. 2017 May 15;30(5):1145-1156. doi: 10.1021/acs.chemrestox.6b00459. Epub 2017 Apr 25.

PMID:
28398727
37.

Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds.

Lepri S, Ceccarelli M, Milani N, Tortorella S, Cucco A, Valeri A, Goracci L, Brink A, Cruciani G.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3178-E3187. doi: 10.1073/pnas.1618881114. Epub 2017 Apr 3.

38.

Improved Potency of Indole-Based NorA Efflux Pump Inhibitors: From Serendipity toward Rational Design and Development.

Buonerba F, Lepri S, Goracci L, Schindler BD, Seo SM, Kaatz GW, Cruciani G.

J Med Chem. 2017 Jan 12;60(1):517-523. doi: 10.1021/acs.jmedchem.6b01281. Epub 2016 Dec 15.

PMID:
27977195
39.

Sequence protein identification by randomized sequence database and transcriptome mass spectrometry (SPIDER-TMS): from manual to automatic application of a 'de novo sequencing' approach.

Pascale R, Grossi G, Cruciani G, Mecca G, Santoro D, Sarli Calace R, Falabella P, Bianco G.

Eur J Mass Spectrom (Chichester). 2016;22(4):193-198.

PMID:
27882884
40.

Vitamin E: Emerging aspects and new directions.

Galli F, Azzi A, Birringer M, Cook-Mills JM, Eggersdorfer M, Frank J, Cruciani G, Lorkowski S, Özer NK.

Free Radic Biol Med. 2017 Jan;102:16-36. doi: 10.1016/j.freeradbiomed.2016.09.017. Epub 2016 Nov 2. Review.

PMID:
27816611
41.

Multiclass method for the determination of 62 antibiotics in milk.

Moretti S, Cruciani G, Romanelli S, Rossi R, Saluti G, Galarini R.

J Mass Spectrom. 2016 Sep;51(9):792-804. doi: 10.1002/jms.3834.

PMID:
27490945
42.

Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case.

Siragusa L, Luciani R, Borsari C, Ferrari S, Costi MP, Cruciani G, Spyrakis F.

ChemMedChem. 2016 Aug 5;11(15):1653-66. doi: 10.1002/cmdc.201600121. Epub 2016 Jul 12.

43.

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

Smith M, De Bono J, Sternberg C, Le Moulec S, Oudard S, De Giorgi U, Krainer M, Bergman A, Hoelzer W, De Wit R, Bögemann M, Saad F, Cruciani G, Thiery-Vuillemin A, Feyerabend S, Miller K, Houédé N, Hussain S, Lam E, Polikoff J, Stenzl A, Mainwaring P, Ramies D, Hessel C, Weitzman A, Fizazi K.

J Clin Oncol. 2016 Sep 1;34(25):3005-13. doi: 10.1200/JCO.2015.65.5597. Epub 2016 Jul 11.

PMID:
27400947
44.

Metabolism study and biological evaluation of bosentan derivatives.

Lepri S, Goracci L, Valeri A, Cruciani G.

Eur J Med Chem. 2016 Oct 4;121:658-670. doi: 10.1016/j.ejmech.2016.06.006. Epub 2016 Jun 6.

PMID:
27318985
45.

Effects of different routes of application on ethylenediurea persistence in tobacco leaves.

Pasqualini S, Paoletti E, Cruciani G, Pellegrino R, Ederli L.

Environ Pollut. 2016 May;212:559-564. doi: 10.1016/j.envpol.2016.03.017. Epub 2016 Mar 12.

PMID:
26977961
46.

Analytical strategies to assess the functional metabolome of vitamin E.

Torquato P, Ripa O, Giusepponi D, Galarini R, Bartolini D, Wallert M, Pellegrino R, Cruciani G, Lorkowski S, Birringer M, Mazzini F, Galli F.

J Pharm Biomed Anal. 2016 May 30;124:399-412. doi: 10.1016/j.jpba.2016.01.056. Epub 2016 Feb 3. Review.

PMID:
26947319
47.

Cyto- and enzyme toxicities of ionic liquids modelled on the basis of VolSurf+ descriptors and their principal properties.

Paternò A, Bocci G, Cruciani G, Fortuna CG, Goracci L, Sciré S, Musumarra G.

SAR QSAR Environ Res. 2016 Mar;27(3):221-244. doi: 10.1080/1062936X.2016.1156571.

PMID:
30950653
48.

Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study.

Lepri S, Buonerba F, Goracci L, Velilla I, Ruzziconi R, Schindler BD, Seo SM, Kaatz GW, Cruciani G.

J Med Chem. 2016 Feb 11;59(3):867-91. doi: 10.1021/acs.jmedchem.5b01219. Epub 2016 Jan 26.

PMID:
26757340
49.

Screening and confirmatory method for multiclass determination of 62 antibiotics in meat.

Moretti S, Dusi G, Giusepponi D, Pellicciotti S, Rossi R, Saluti G, Cruciani G, Galarini R.

J Chromatogr A. 2016 Jan 15;1429:175-88. doi: 10.1016/j.chroma.2015.12.021. Epub 2015 Dec 11.

PMID:
26726937
50.

Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore.

Tondi D, Cross S, Venturelli A, Costi MP, Cruciani G, Spyrakis F.

Curr Drug Targets. 2016;17(9):983-1005. Review.

PMID:
26424401

Supplemental Content

Loading ...
Support Center